News and Updates
eMediNexus Coverage from: 
Delhi High Court dismisses pleas against Centre's ban on anti-diabetic FDC medicines
eMediNexus,  10 January 2019
remove_red_eye 573 Views
#Diabetes and Endocrinology #Internal Medicine

1 Read Comments                

New Delhi: The Delhi High Court has rejected a batch of pleas challenging the Centres notification banning manufacture and sale of fixed dose combination (FDC) drugs used for treatment of Type-II diabetes. Justice Vibhu Bakhru said there was no ground to interfere with the central governments September 7, 2018, notification and dismissed the petitions filed by eight pharma companies. The Centre had banned the FDCs of formulation of metformin, pioglitazone and glimepiride of varying compositions. These F
To continue reading this article
Sign in with Medtalks

Continue reading your article with a eMediNexus account.
Free Membership!